NCT00525720 2026-03-09
Brachytherapy for Prostatic Carcinoma Patients
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
57 trialsNCT01946529 2026-02-23
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT05320406 2026-02-12
REVELUTION
Emory University
Phase 2 Active not recruiting
NCT01871766 2025-12-17
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT07276360 2025-12-11
HypoRTCx-UG
Uganda Cancer Institute
Phase 2 Not yet recruiting
NCT07232654 2025-12-01
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT05100472 2025-11-04
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT04253483 2025-09-17
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
Rutgers, The State University of New Jersey
Phase 2 Active not recruiting
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT07152678 2025-09-03
BRIGHT-ESCC
National Taiwan University Hospital
Phase 2 Recruiting
NCT06023641 2025-08-19
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
St. Jude Children's Research Hospital
Phase 2 Recruiting
NCT03290534 2025-04-04
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®
CivaTech Oncology
Phase 2 Recruiting
NCT06872606 2025-03-12
SCRIPBOT
Sir Run Run Shaw Hospital
Phase 2 Not yet recruiting
NCT06524778 2024-08-07
Single High-dose Brachytherapy for Giant Osteosarcoma Masses
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase 2 Not yet recruiting
NCT03753659 2024-07-22
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT06419673 2024-05-17
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Active not recruiting
NCT01783535 2024-04-16
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
St. Jude Children's Research Hospital
Phase 2 Active not recruiting
NCT02280356 2024-03-04
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT06129851 2023-11-13
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer
University of Kansas Medical Center
Phase 2 Not yet recruiting
NCT01041027 2023-10-26
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
Albert Einstein College of Medicine
Phase 2 Terminated
NCT05799469 2023-04-05
Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer
Chongqing University Cancer Hospital
Phase 2 Not yet recruiting
NCT00492778 2023-03-29
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
GOG Foundation
Phase 2 Unknown
NCT05772377 2023-03-16
Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT01399658 2023-03-14
AMIGO
Dana-Farber Cancer Institute
Phase 2 Completed
NCT00450411 2022-06-21
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy
Radiation Therapy Oncology Group
Phase 2 Completed
NCT05105672 2021-12-28
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
The Affiliated Hospital of Xuzhou Medical University
Phase 2 Unknown
NCT01802307 2021-05-11
Focal Therapy for Prostate Cancer
University of Maryland, Baltimore
Phase 2 Withdrawn
NCT03541928 2021-04-06
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
The Methodist Hospital Research Institute
Phase 2 Unknown
NCT00006365 2020-10-22
External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer
Radiation Therapy Oncology Group
Phase 2 Completed
NCT01859689 2020-07-27
Internal Radiation Therapy in Treating Patients With Low-Risk Prostate Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT01374087 2019-09-18
ANABRAQ
Ipsen
Phase 2 Terminated
NCT00714753 2019-08-07
Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer
Mayo Clinic
Phase 2 Completed
NCT01552239 2018-10-16
PREMISS
Technical University of Munich
Phase 2 Unknown
NCT03469531 2018-08-13
Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Zhujiang Hospital
Phase 2 Unknown
NCT00039624 2018-08-02
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00290654 2017-12-28
Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ
Masonic Cancer Center, University of Minnesota
Phase 2 Terminated
NCT00002492 2016-12-15
Combination Chemotherapy in Treating Patients With Soft Tissue Sarcoma
University of Miami
Phase 2 Completed
NCT00032006 2016-07-13
Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT02501278 2016-05-13
A Phase II Clinical Trial of Chemo-radiotherapy in Combination With INO-3112 in Patients With Locally Advanced Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Withdrawn
NCT02705612 2016-03-10
Phase II Clinical Trial of Concurrent Chemoradiotherapy Combined Nimotuzumab for Stage IIB-IVA Cervical Cancer
Air Force Military Medical University, China
Phase 2 Unknown
NCT00983541 2015-08-19
Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma
University of Utah
Phase 2 Terminated
NCT02423226 2015-04-22
Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer
The First People's Hospital of Changzhou
Phase 2 Completed
NCT00002804 2014-07-25
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
Children's Oncology Group
Phase 2 Completed
NCT01301612 2014-07-14
Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)
Eurofarma Laboratorios S.A.
Phase 2 Withdrawn
NCT00002791 2014-01-24
Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
Radiation Therapy Oncology Group
Phase 2 Completed
NCT00462397 2013-08-26
Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00008112 2013-08-07
Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00002689 2013-07-18
Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00017160 2013-06-27
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Radiation Therapy Oncology Group
Phase 2 Withdrawn
NCT00003574 2013-06-21
Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors
National Cancer Institute (NCI)
Phase 2 Completed